A prospective evaluation of the temporal matrix metalloproteinase response after severe traumatic brain injury in humans

Journal of Neurotrauma

Volumn 30, Issue 20, 2013, Pages 1717-1726

  Roberts, Derek J ^a   Jenne, Craig N ^a   Léger, Caroline ^a   Kramer, Andreas H ^a   Gallagher, Clare N ^a   Todd, Stephanie ^a   Parney, Ian F ^b   Doig, Christopher J ^a   Yong, V Wee ^a   Kubes, Paul ^a,c   Zygun, David A ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b Mayo Clinic College of Medicine   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

brain injuries; cerebrospinal fluid; craniocerebral trauma; matrix metalloproteinase; microdialysis

Indexed keywords

GELATINASE A; GELATINASE B; GLUCOSE; INTERSTITIAL COLLAGENASE; LACTIC ACID; MATRILYSIN; NEUTROPHIL COLLAGENASE; PYRUVIC ACID; STROMELYSIN;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN OXYGEN TENSION; CEREBRAL PERFUSION PRESSURE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CRITICAL ILLNESS; DIALYSATE; EVALUATION; FEMALE; HOSPITAL DISCHARGE; HUMAN; INJURY SEVERITY; INTRACRANIAL PRESSURE; MALE; MICRODIALYSIS; MORTALITY; OUTCOME ASSESSMENT; PERFUSION PRESSURE; PROSPECTIVE STUDY; TRAUMATIC BRAIN INJURY;

ADULT; BRAIN; BRAIN INJURIES; CRITICAL ILLNESS; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MATRIX METALLOPROTEINASES; MICRODIALYSIS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84885588793     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2012.2841     Document Type: Article

References (42)

1. Maas, A.I., Stocchetti, N., and Bullock, R. (2008). Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7, 728-741
2. Nortje, J., and Menon, D.K. (2004). Traumatic brain injury: Physiology, mechanisms, and outcome. Curr. Opin. Neurol. 17, 711-718
3. Wang, X., Jung, J., Asahi, M., Chwang, W., Russo, L., Moskowitz, M.A., Dixon, C.E., Fini, M.E., and Lo, E.H. (2000). Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037-7042
4. Mori, T., Wang, X., Aoki, T., and Lo, E.H. (2002). Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J. Neurotrauma 19, 1411-1419
5. Kawai, N., Kawanishi, M., Okada, M., Matsumoto, Y., and Nagao, S. (2003). Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats. J. Neurotrauma 20, 649-657
6. Kim, H.J., Fillmore, H.L., Reeves, T.M., and Phillips, L.L. (2005). Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis. Exp. Neurol. 192, 60-72
7. Falo, M.C., Fillmore, H.L., Reeves, T.M., and Phillips, L.L. (2006). Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J. Neurosci. Res. 84, 768-781
8. Lescot, T., Fulla-Oller, L., Palmier, B., Po, C., Beziaud, T., Puybasset, L., Plotkine, M., Gillet, B., Meric, P., and Marchand- Leroux, C. (2010). Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats. J. Neurotrauma 27, 1069-1079
9. Higashida, T., Kreipke, C.W., Rafols, J.A., Peng, C., Schafer, S., Schafer, P., Ding, J.Y., Dornbos, D. 3rd, Li, X., Guthikonda, M., Rossi, N.F., and Ding, Y. (2011). The role of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 in blood- brain barrier disruption and brain edema after traumatic brain injury. J. Neurosurg. 114, 92-101
10. Yong, V.W., Power, C., Forsyth, P., and Edwards, D.R. (2001). Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511
11. Yong, V.W. (2005). Metalloproteinases: Mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931-944
12. Zhang, H., Adwanikar, H., Werb, Z., and Noble-Haeusslein, L.J. (2010). Matrix metalloproteinases and neurotrauma: Evolving roles in injury and reparative processes. Neuroscientist 16, 156-170
13. Van Hove, I., Lemmens, K., Van de Velde, S., Verslegers, M., and Moons, L. (2012). Matrix metalloproteinase-3 in the central nervous system: A look on the bright side. J Neurochem. 123, 203-216
14. Vilalta, A., Sahuquillo, J., Rosell, A., Poca, M.A., Riveiro, M., and Montaner, J. (2008). Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases. Intensive Care Med. 34, 1384-1392
15. Grossetete, M., Phelps, J., Arko, L., Yonas, H., and Rosenberg, G.A. (2009). Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery 65, 702-708
16. Teasdale, G., and Jennett, B. (1974). Assessment of coma and impaired consciousness. A practical scale. Lancet 2, 81-84
17. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton, S.L., Chestnut, R.M., Ghajar, J., McConnell Hammond, F.F., Harris, O.A., Hartl, R., Manley, G.T., Nemecek, A., Newell, D.W., Rosenthal, G., Schouten, J., Shutter, L., Timmons, S.D., Ullman, J.S., Videtta, W., Wilberger, J.E., and Wright, D.W. (2007). Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J. Neurotrauma 24, Suppl. 1, S37-S44
18. Brain Trauma Foundation, American Association of Neurological Surgeons, and Congress of Neurological Surgeons (2007). Guidelines for the management of severe traumatic brain injury. J. Neurotrauma 24, Suppl. 1, S1-S106
19. Bellander, B.M., Cantais, E., Enblad, P., Hutchinson, P., Nordstro?m, C.H., Robertson, C., Sahuquillo, J., Smith, M., Stocchetti, N., Ungerstedt, U., Unterberg, A., and Olsen, N.V. (2004). Consensus meeting on microdialysis in neurointensive care. Intensive Care Med. 30, 2166-2169
20. Hutchinson P.J., O?Connell, M.T., al-Rawi, P.G., Kett-White, R., Gupta, A.K., Kirkpatrick, P.J., and Pickard, J.D. (2002). Clinical cerebral microdialysis-determining the true extracellular concentration. Acta Neurochir. Suppl. 81, 359-362
21. Marshall, L.F., Marshall, S.B., Klauber, M.R., Van Berkum Clark, M., Eisenberg, H.M., Jane, J.A., Luerssen, T.G., Marmarou, A., and Foulkes, M.A. (1991). A new classification of head injury based on computerized tomography. J. Neurosurg. 75, Suppl., S14-S20
22. Marshall LF, Gautille T, Klauber MR, Eisenberg, H.M., Jane, J.A., Luerssen, T.G., Marmarou, A., and Foulkes, M.A. (1991). The outcome of severe closed head injury. J. Neurosurg. 75, S28-S36
23. Jennett, B., and Bond, M. (1975). Assessment of outcome after severe brain damage. Lancet 1, 480-484
24. Dupont, N.C., Wang, K., Wadhwa, P.D., Culhane, J.F., and Nelson, E.L. (2005). Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants. J. Reprod. Immunol. 66, 175-191
25. Vittinghoff, E., Glidden, D.V., Shoboski, S.C, and McCulloch, C.E. (2012). Repeated measures and longitudinal data analysis, in: Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models Second Edition. E. Vittinghoff, D.V. Glidden, S.C. Shiboski, and C.E. McCulloch (eds.). Springer: New York, pps. 261-308
26. Helmy, A., Carpenter, K.L., Menon, D.K., Pickard, J.D., and Hutchinson, P.J. (2011). The cytokine response to human traumatic brain injury: Temporal profiles and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 31, 658-670
27. Helmy, A., De Simoni, M.G., Guilfoyle, M.R., Carpenter, K.L., and Hutchinson, P.J. (2011). Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog. Neurobiol. 95, 352-372
28. Roberts, D.J., and Goralski, K.B. (2008). A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin. Drug Metab. Toxicol. 4, 1245-1264
29. Rosenberg, G.A., Kornfeld, M., Estrada, E., Kelley, R.O., Liotta, L.A., and Stetler-Stevenson, W.G. (1992). TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 576, 203-207
30. Reyes, R., Guo, M., Swann, K., Shetgeri, S.U., Sprague, S.M., Jimenez, D.F., Barone, C.M., and Ding, Y. (2009). Role of tumor necrosis factor-alpha and matrix metalloproteinase-9 in blood-brain barrier disruption after peripheral thermal injury in rats. J. Neurosurg. 110, 1218-1226
31. Gurney, K.J., Estrada, E.Y., and Rosenberg, G.A. (2006). Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol. Dis. 23, 87-96
32. Bauer, A.T., Burgers, H.F., Rabie, T., and Marti, H.H. (2010). Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 30, 837-848
33. Falo, M.C., Reeves, T.M., and Phillips, L.L. (2008). Agrin expression during synaptogenesis induced by traumatic brain injury. J. Neurotrauma 25, 769-783
34. Bilousova, T.V., Rusakov, D.A., Ethell, D.W., and Ethell, I.M. (2006). Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J. Neurochem. 97, 44-56
35. Szklarczyk, A., Ewaleifoh, O., Beique, J.C., Wang, Y., Knorr, D., Haughey, N., Malpica, T., Mattson, M.P., Huganir, R., and Conant, K. (2008). MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function. FASEB J. 22, 3757-3767
36. Nygardas, P.T., and Hinkkanen, A.E. (2002). Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 128, 245-254
37. Bar-Or, A., Nuttall, R.K., Duddy, M., Alter, A., Kim, H.J., Ifergan, I., Pennington, C.J., Bourgoin, P., Edwards, D.R., and Yong, V.W. (2003). Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126, 2738-2749
38. Folgueras, A.R., Fueyo, A., Garcia-Suarez, O., Cox, J., Astudillo, A., Tortorella, P., Campestre, C., Gutiérrez-Fernández, A., Fanjul-Ferna ́ndez, M., Pennington, C.J., Edwards, D.R., Overall, C.M., and López-Ot?́n, C. (2008). Collagenase-2 deficiency or inhibition impairs experimental autoimmune encephalomyelitis in mice. J. Biol. Chem. 283, 9465-9474
39. Vilalta, A., Sahuquillo, J., Poca, M.A., De Los Rios, J., Cuadrado, E., Ortega-Aznar, A., Riveiro, M., and Montaner, J. (2008). Brain contusions induce a strong local overexpression of MMP-9. Results of a pilot study. Acta Neurochir. Suppl. 102, 415-419
40. Kramer, A.H., Roberts, D.J., and Zygun, D.A. (2012). Optimal glycemic control in neurocritical care patients: A systematic review and meta-analysis. Crit. Care 16, R203
41. Chen, J., Cui, X., Zacharek, A., Cui, Y., Roberts, C., and Chopp, M. (2011). White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke 42, 445-452
42. Kumari, R., Willing, L.B., Patel, S.D., Baskerville, K.A., and Simpson, I.A. (2011). Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke. J. Neurochem. 119, 1029